or Try an Advanced Search...

    Technical Analysis for EPRX - Eupraxia Pharmaceuticals Inc.

    Grade Last Price % Change Price Change
    D 2.76 2.22% 0.06
    EPRX closed up 2.22 percent on Wednesday, September 18, 2024, on 40 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Up Up
    Historical EPRX trend table...
    Date Alert Name Type % Chg
    MACD Bullish Centerline Cross Bullish 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Crossed Above 20 DMA Bullish 2.22%
    Crossed Above 50 DMA Bullish 2.22%
    Inside Day Range Contraction 2.22%
    Gapped Up Strength 2.22%
    20 DMA Resistance Bearish 7.81%
    50 DMA Resistance Bearish 7.81%
    MACD Bullish Signal Line Cross Bullish 7.81%
    Wide Range Bar Range Expansion 7.81%
    Older End-of-Day Signals for EPRX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 18 hours ago
    Rose Above Upper Bollinger Band about 18 hours ago
    Up 3% about 18 hours ago
    Down 1% about 18 hours ago
    Up 2% about 18 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    EPRX Chart by TradingView
    Basic chart:

    Profile

    Eupraxia Pharmaceuticals, Inc. operates as a drug delivery technology company in Canada. It delivers drugs into body compartments, such as the joint without any of the common issues with body compartment injections, such as systemic exposure. The firm focuses on arthritis, diabetic macular edema, and chronic pain programs. The company was founded by James A. Helliwell and John Salvatore Montalbano on May 12, 2011 and is headquartered in Victoria, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Chronic Pain Chronic Condition Diabetic Retinopathy Macular Edema Arthritis Diabetic Macular Edema Drug Delivery Technology Medical Signs

    Is EPRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 11 Eupraxia Pharmaceuticals Announces Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
    Sep 4 Eupraxia Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Aug 2 Eupraxia Pharmaceutical enters into C$12M convertible debt facility
    Aug 2 Eupraxia Pharmaceuticals Announces New C$12 Million Convertible Debt Facility
    Jul 3 Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Exploring the Rapid Rise of Osteoarthritis" on July 9, 2024
    May 23 Eupraxia Pharmaceuticals Announces Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
    May 22 Eupraxia Pharmaceuticals to Host Virtual KOL Event on EP-104GI Clinical Development Program for Eosinophilic Esophagitis ("EoE") on May 29, 2024
    May 21 Eupraxia Pharmaceuticals Announces New Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
    May 9 Eupraxia Pharmaceuticals reports Q1 results
    May 8 Eupraxia Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
    See more EPRX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.55
    52 Week Low 2.39
    Average Volume 7,831
    200-Day Moving Average 0.00
    50-Day Moving Average 2.62
    20-Day Moving Average 2.60
    10-Day Moving Average 2.58
    Average True Range 0.19
    RSI (14) 56.14
    ADX 13.79
    +DI 26.00
    -DI 14.04
    Chandelier Exit (Long, 3 ATRs) 2.28
    Chandelier Exit (Short, 3 ATRs) 2.98
    Upper Bollinger Bands 2.79
    Lower Bollinger Band 2.41
    Percent B (%b) 0.93
    BandWidth 14.71
    MACD Line 0.00
    MACD Signal Line -0.02
    MACD Histogram 0.0205
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.00
    Resistance 3 (R3) 2.99 2.90 2.96
    Resistance 2 (R2) 2.90 2.84 2.90 2.95
    Resistance 1 (R1) 2.83 2.80 2.86 2.84 2.93
    Pivot Point 2.74 2.74 2.76 2.75 2.74
    Support 1 (S1) 2.67 2.68 2.71 2.68 2.59
    Support 2 (S2) 2.58 2.64 2.59 2.57
    Support 3 (S3) 2.51 2.58 2.56
    Support 4 (S4) 2.52